Mobile Health Self-Management Intervention for Patient With Chronic Obstructive Pulmonary Disease (NCT07469904) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Mobile Health Self-Management Intervention for Patient With Chronic Obstructive Pulmonary Disease
Indonesia126 participantsStarted 2026-03-26
Plain-language summary
This clinical trial aims to evaluate the effectiveness of a pharmacist-led interactive mobile health intervention (serious game) in adults aged 50 years and older with chronic obstructive pulmonary disease (COPD). The study will test whether the intervention improves health status compared with usual care. Secondary outcomes include inhaler technique, medication adherence, health knowledge, dyspnea, clinical events, healthcare utilization, and costs. Participants in the intervention group will receive pharmacist guidance and use the serious game at home for 2 weeks.
Who can participate
Age range
50 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 50 years and older
* Diagnosed with chronic obstructive pulmonary disease (COPD) and clinically stable at the time of enrollment
* Receiving inhalation therapy
* Able to use or access a smartphone
* Able to communicate in Bahasa Indonesia
* Willing to participate and provide informed consent
Exclusion Criteria:
* Other respiratory diseases (active tuberculosis, lung cancer, asthma, and pneumonia)
* Serious comorbidities (renal insufficiency and cardiac failure, terminal illness, life expectancy \<6 m)
* mental disorders or cognitive dysfunction
* auditory, visual, or verbal inability
* participation in other intervention studies
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in COPD health status
Timeframe: Baseline, 1 month, 2 months and 3 months
Trial details
NCT IDNCT07469904
SponsorUniversitas Katolik Widya Mandala Surabaya
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2026-06
Contact for this trial
Galuh Nawang Prawesti, Master of Clinical Pharmacy